2022 |
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis |
Articolo in rivista |
Vai |
2022 |
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
Articolo in rivista |
Vai |
2022 |
How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation? |
Articolo in rivista |
Vai |
2022 |
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence |
Articolo in rivista |
Vai |
2022 |
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints |
Articolo in rivista |
Vai |
2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2022 |
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2022 |
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model |
Articolo in rivista |
Vai |
2021 |
Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection |
Articolo in rivista |
Vai |
2021 |
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment |
Articolo in rivista |
Vai |
2021 |
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival |
Articolo in rivista |
Vai |
2021 |
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) |
Articolo in rivista |
Vai |
2021 |
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use |
Articolo in rivista |
Vai |
2021 |
Young gastrointestinal angle: E-learning in gastroenterology: Future is now |
Articolo in rivista |
Vai |
2021 |
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals |
Articolo in rivista |
Vai |
2021 |
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? |
Articolo in rivista |
Vai |
2021 |
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort |
Articolo in rivista |
Vai |
2021 |
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) |
Articolo in rivista |
Vai |
2021 |
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis |
Articolo in rivista |
Vai |
2021 |
Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling |
Articolo in rivista |
Vai |
2020 |
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases |
Articolo in rivista |
Vai |
2020 |
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease |
Articolo in rivista |
Vai |
2020 |
Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis |
Articolo in rivista |
Vai |
2020 |
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma |
Articolo in rivista |
Vai |
2020 |
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort |
Articolo in rivista |
Vai |
2020 |
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2019 |
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Articolo in rivista |
Vai |
2019 |
Outcomes of hepatocellular carcinoma patients treated with sorafenib: A meta-analysis of Phase III trials |
Articolo in rivista |
Vai |
2019 |
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience |
Articolo in rivista |
Vai |
2019 |
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy |
Articolo in rivista |
Vai |
2019 |
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2019 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis |
Articolo in rivista |
Vai |
2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
2018 |
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma? |
Articolo in rivista |
Vai |
2018 |
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? |
Articolo in rivista |
Vai |
2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Vai |
2018 |
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. |
Articolo in rivista |
Vai |
2018 |
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort |
Poster pubblicato in rivista |
Vai |
2018 |
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis |
Articolo in rivista |
Vai |
2017 |
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study |
Articolo in rivista |
Vai |
2017 |
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma |
Articolo in rivista |
Vai |
2017 |
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma |
Articolo in rivista |
Vai |
2017 |
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD |
Articolo in rivista |
Vai |
2017 |
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity |
Articolo in rivista |
Vai |
2017 |
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values |
Articolo in rivista |
Vai |
2017 |
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter |
Articolo in rivista |
Vai |
2017 |
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon |
Articolo in rivista |
Vai |
2017 |
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. |
Articolo in rivista |
Vai |
2017 |
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2016 |
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies |
Articolo in rivista |
Vai |
2016 |
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis |
Review essay (rassegna critica) |
Vai |
2016 |
The evolutionary scenario of hepatocellular carcinoma in Italy: an update |
Abstract in rivista |
Vai |
2016 |
Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective? |
Articolo in rivista |
Vai |
2016 |
Prioritization of high-cost new drugs for HCV: making sustainability ethical |
Articolo in rivista |
Vai |
2016 |
Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis |
Abstract in rivista |
Vai |
2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
2016 |
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model |
Articolo in rivista |
Vai |
2016 |
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing |
Lettera |
Vai |
2016 |
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2016 |
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease |
Articolo in rivista |
Vai |
2016 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2016 |
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study |
Articolo in rivista |
Vai |
2015 |
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis |
Articolo in rivista |
Vai |
2015 |
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity |
Abstract in rivista |
Vai |
2015 |
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
Articolo in rivista |
Vai |
2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C |
Articolo in rivista |
Vai |
2015 |
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES |
Articolo in rivista |
Vai |
2015 |
Sorafenib for hepatocellular carcinoma: From randomized controlled trials to clinical practice |
Articolo in rivista |
Vai |
2015 |
HCV: The best cure possible or the best possible cure? |
Nota o commento |
Vai |
2015 |
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors |
Articolo in rivista |
Vai |
2015 |
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2015 |
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2015 |
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib |
Articolo in rivista |
Vai |
2015 |
Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure |
Articolo in rivista |
Vai |
2015 |
Refining sorafenib therapy: Lessons from clinical practice |
Articolo in rivista |
Vai |
2015 |
Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy |
Articolo in rivista |
Vai |
2015 |
Reply |
Lettera |
Vai |
2015 |
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis |
Articolo in rivista |
Vai |
2015 |
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2014 |
Clinical implications of the hyperdynamic syndrome in cirrhosis. |
Articolo in rivista |
Vai |
2014 |
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2014 |
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants |
Articolo in rivista |
Vai |
2014 |
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2014 |
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2014 |
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women |
Abstract in rivista |
Vai |
2014 |
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. |
Articolo in rivista |
Vai |
2013 |
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
2013 |
Chemoprevention for hepatocellular carcinoma: the role of statins |
Articolo in rivista |
Vai |
2013 |
Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age? |
Articolo in rivista |
Vai |
2013 |
Assessment of treatment response in hepatocellular carcinoma: a review of literature |
Abstract in rivista |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
eedings |
Vai |
2013 |
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2013 |
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection |
Articolo in rivista |
Vai |
2013 |
Survival of Patients with Hepatocellular Carcinoma (HCC)
Treated by Percutaneous Radio-Frequency Ablation
(RFA) Is Affected by Complete Radiological Response |
Abstract in rivista |
Vai |
2013 |
Treatment of hepatocellular carcinoma: present and future. |
Articolo in rivista |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
2013 |
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. |
Articolo in rivista |
Vai |
2013 |
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2012 |
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study |
Articolo in rivista |
Vai |
2012 |
Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. |
Articolo in rivista |
Vai |
2012 |
Peginterferon-A_2B plus ribavirin is more effective than
peginterferon-A_2A plus ribavirin in menopausal women
with chronic hepatitis C |
Articolo in rivista |
Vai |
2012 |
Reproductive status is associated with the severity of fibrosis in women with hepatitis C |
Articolo in rivista |
Vai |
2012 |
Causes of and prevention strategies for hepatocellular carcinoma. |
Articolo in rivista |
Vai |
2012 |
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. |
Articolo in rivista |
Vai |
2012 |
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with
Genotype 1 Chronic Hepatitis C |
Articolo in rivista |
Vai |
2012 |
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in
patients with chronic liver diseases. |
Articolo in rivista |
Vai |
2012 |
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. |
Articolo in rivista |
Vai |
2012 |
Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply |
Articolo in rivista |
Vai |
2012 |
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. |
Articolo in rivista |
Vai |
2012 |
Hepatitis C in the elderly: a multicentre
cross-sectional study by the Italian Association for the Study of the Liver |
Articolo in rivista |
Vai |
2012 |
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2012 |
Methylenetetrahydrofolate reductase homozygosis
and low-density lipoproteins in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2012 |
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea |
Articolo in rivista |
Vai |
2012 |
Enoxaparin Prevents Portal Vein Thrombosis
and Liver Decompensation in Patients With Advanced Cirrhosis. |
Articolo in rivista |
Vai |
2012 |
Hyperuricaemia:
another metabolic feature affecting the severity of chronic hepatitis because of
HCV infection. |
Articolo in rivista |
Vai |
2011 |
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. |
Articolo in rivista |
Vai |
2011 |
Predicting survival in patients with hepatocellular carcinoma
treated by transarterial chemoembolisation |
Articolo in rivista |
Vai |
2011 |
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. |
Articolo in rivista |
Vai |
2011 |
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
2011 |
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. |
Articolo in rivista |
Vai |
2011 |
Genetic predisposition to thrombophilia in inflammatory bowel disease |
Articolo in rivista |
Vai |
2011 |
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
2011 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2011 |
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. |
Articolo in rivista |
Vai |
2011 |
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. |
Articolo in rivista |
Vai |
2011 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
2011 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
2011 |
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. |
Articolo in rivista |
Vai |
2010 |
Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons |
Articolo in rivista |
Vai |
2010 |
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data |
Articolo in rivista |
Vai |
2010 |
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. |
Articolo in rivista |
Vai |
2010 |
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. |
Articolo in rivista |
Vai |
2010 |
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2010 |
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
2010 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Vai |
2010 |
HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B |
eedings |
Vai |
2009 |
Two yr mycophenolate
mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver
transplant. |
Articolo in rivista |
Vai |
2009 |
Prognostic scores for hepatocellular carcinoma: none is the winner. |
Articolo in rivista |
Vai |
2009 |
Reply |
Articolo in rivista |
Vai |
2009 |
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy |
Articolo in rivista |
Vai |
2009 |
Retreatment with pegylated interferon plus ribavirin of chronic
hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. |
Articolo in rivista |
Vai |
2009 |
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. |
Articolo in rivista |
Vai |
2009 |
Reply |
Articolo in rivista |
Vai |
2009 |
Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. |
Articolo in rivista |
Vai |
2009 |
Time course of insulin resistance during antiviral
therapy in non-diabetic, non-cirrhotic patients with
genotype 1 HCV infection |
Articolo in rivista |
Vai |
2009 |
Insulin resistance in HCV mono-infected and in HIV/HCV
co-infected patients: Looking to the future. |
Articolo in rivista |
Vai |
2009 |
Hyperferritinemia is a risk factor
for steatosis in chronic liver disease. |
Articolo in rivista |
Vai |
2009 |
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis |
Articolo in rivista |
Vai |
2008 |
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2008 |
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS |
Articolo in rivista |
Vai |
2008 |
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease |
Articolo in rivista |
Vai |
2008 |
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. |
Articolo in rivista |
Vai |
2008 |
Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over
a 21-year period in 148 patients. |
Articolo in rivista |
Vai |
2008 |
Insulin resistance and diabetes increase fibrosis in the liver of patients with
genotype 1 HCV infection. |
Articolo in rivista |
Vai |
2008 |
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems |
Articolo in rivista |
Vai |
2008 |
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis |
Articolo in rivista |
Vai |
2008 |
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to
End-Stage Liver Disease |
Articolo in rivista |
Vai |
2008 |
Reply |
Articolo in rivista |
Vai |
2007 |
Transjugular Intrahepatic Portosystemic Shunt For Refractory Ascites: A Meta-Analysis Of Individual Patient Data |
Articolo in rivista |
Vai |
2007 |
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. |
Articolo in rivista |
Vai |
2007 |
a meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative maintenance therapy in Crohn's disease |
eedings |
Vai |
2007 |
Epidemiological profile of 806 Italian children with hepatitis C virus
infection over a 15-year period. |
Articolo in rivista |
Vai |
2007 |
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner |
eedings |
Vai |
2007 |
INSULIN RESISTANCE AND SEVERITY OF
FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. |
eedings |
Vai |
2006 |
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2006 |
Treating patients with HCV genotype 1 and low viraemia: more than meets the eye |
Articolo in rivista |
Vai |
2006 |
Treatment options in HBV. |
Articolo in rivista |
Vai |
2006 |
Chemoprevention of hepatocellular carcinoma. |
Capitolo o Saggio |
Vai |
2006 |
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. |
Articolo in rivista |
Vai |
2005 |
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study |
Articolo in rivista |
Vai |
2005 |
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study |
Articolo in rivista |
Vai |
2005 |
Prevention of hepatocellular carcinoma |
Articolo in rivista |
Vai |
2005 |
Treatment of hepatitis C: critical appraisal of the evidence |
Articolo in rivista |
Vai |
2005 |
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center |
Articolo in rivista |
Vai |
2005 |
Il carcinoma dell'esofago |
Articolo in rivista |
Vai |
2004 |
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing |
Abstract in rivista |
Vai |
2004 |
Unsatisfactory quality of hepatological information on the internet |
Articolo in rivista |
Vai |
2004 |
UNRESECTABLE HEPATOCELLULAR CARCINOMA:META-ANALYSIS OD ARTERIAL EMBOLIZATION |
Articolo in rivista |
Vai |
2004 |
Percutaneous radiofrequency therma ablation of small hepatocellular carcinoma: a prospective study |
eedings |
Vai |
2004 |
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach |
Articolo in rivista |
Vai |
2004 |
PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION 8 RFTA) OF SMALL HEPATOCELLUALR CARCINOMA: A PROSPECTIVE STUDY |
Articolo in rivista |
Vai |
2004 |
La termoablazione nel trattamento delle neoplasie epatiche primitive e secondarie |
Articolo in rivista |
Vai |
2004 |
Quality-related variables at hepatological websites |
Articolo in rivista |
Vai |
2004 |
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis |
Articolo in rivista |
Vai |
2004 |
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial |
Articolo in rivista |
Vai |
2004 |
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years |
Articolo in rivista |
Vai |
2004 |
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy |
Articolo in rivista |
Vai |
2004 |
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance |
Articolo in rivista |
Vai |
2004 |
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data |
Articolo in rivista |
Vai |
2003 |
Il carcinoma del colon-retto: Un approccio basato sulle evidenze |
Articolo in rivista |
Vai |
2003 |
When and how to treat acute hepatitis C? |
Articolo in rivista |
Vai |